EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination

Anne P Werner iD, Cosette G Schneider, Elgin H Akin, Juliahna Hayes, Katherine Z J Fenstermacher iD, Richard E Rothman, Lynda Coughlan iD, Andrew Pekosz iD

mBio · 10.12.2025 · 16 (12)

DOI: 10.1128/mbio.02145-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 10.12.2025. Verfasst von Anne P Werner und 7 weiteren Autor:innen. Beteiligte Einrichtung: W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Neuraminidase, Influenza, Human, Influenza A Virus, H5N1 Subtype. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Richard Eliasberg Family Foundation, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An increase in the number of human cases of influenza A/H5N1 infection in the USA has raised concerns about the pandemic potential of the virus. Pre-existing population immunity is a key determinant for risk assessment and pandemic potential for any virus. Antibody responses against the bovine A/H5N1 hemagglutinin (HA) and neuraminidase (NA) proteins were measured among a population of influenza-vaccinated or influenza-infected individuals. Modest titers of bovine A/H5N1 HA-binding antibodies and low to undetectable neutralizing antibody titers were detected in a cohort of 73 individuals. Conversely, bovine A/H5N1 NA-binding and neuraminidase-inhibiting antibody titers were comparable to those against a human A/H1N1 NA at baseline. Seasonal influenza vaccination failed to significantly increase antibody titers against both HA and NA glycoproteins of bovine A/H5N1. Recent infection with human A/H1N1 but not A/H3N2 viruses induced significant increases in bovine A/H5N1-neutralizing antibody, as well as increases in NA-binding and NA-inhibiting antibodies to bovine A/H5N1 NA. While the degree of protection afforded by these A/H5N1 cross-reactive antibodies is not known, incorporating NA or enhancing current seasonal vaccine formulations to increase NA-specific antibody titers may increase antibody breadth and protection against both seasonal and pandemic influenza viruses. IMPORTANCE A/H5N1 influenza A viruses continue to pose a pandemic threat to humans. Recent infection of dairy cattle and poultry with A/H5N1 in the USA has magnified that concern. We determined the level of antibodies that recognize A/H5N1 hemagglutinin (HA) and neuraminidase (NA) proteins in a population in Baltimore, MD. We show that while low levels of H5 HA-binding and A/H5N1-neutralizing antibodies are present, there is a significantly stronger recognition of bovine N1 NA. Vaccines that target the N1 NA protein may induce protective antibody responses in humans due to the presence of cross-reactive human N1 NA antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralNeuraminidaseInfluenza, HumanInfluenza A Virus, H5N1 SubtypeInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesHemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H3N2 SubtypeViral ProteinsHumansAnimalsCattleAntibodies, NeutralizingAdultMiddle AgedMaleFemaleYoung AdultAdolescentVaccinationAged

Stichwörter der Autor:innen

H5N1hemagglutininneuraminidaseneuraminidase inhibiting antibodyneutralizing antibodypopulation immunity

Substanzen

Antibodies, ViralNeuraminidaseInfluenza VaccinesHemagglutinin Glycoproteins, Influenza VirusAntibodies, NeutralizingNA protein, influenza A virusViral Proteins

Autor:innen und Institutionen

  • W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Anne P Werner, Katherine Z J Fenstermacher, Lynda Coughlan, Andrew Pekosz

Förderung

  • NIAID NIH HHS
  • Richard Eliasberg Family Foundation
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Werner, A. P., Schneider, C. G., Akin, E. H., Hayes, J., Fenstermacher, K. Z. J., Rothman, R. E., Coughlan, L., & Pekosz, A. (2025). Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination. mBio, 16(12). https://doi.org/10.1128/mbio.02145-25

Vancouver

Werner AP, Schneider CG, Akin EH, Hayes J, Fenstermacher KZJ, Rothman RE, et al. Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination. mBio. 2025;16(12). doi:10.1128/mbio.02145-25

BibTeX
@article{Werner2025,
  author = {Werner, Anne P and Schneider, Cosette G and Akin, Elgin H and Hayes, Juliahna and Fenstermacher, Katherine Z J and Rothman, Richard E and Coughlan, Lynda and Pekosz, Andrew},
  title = {Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination},
  journal = {mBio},
  year = {2025},
  volume = {16},
  number = {12},
  doi = {10.1128/mbio.02145-25}
}
Kostenlos starten →